{"id":776746,"date":"2022-04-05T20:00:26","date_gmt":"2022-04-05T18:00:26","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/"},"modified":"2023-07-11T14:07:16","modified_gmt":"2023-07-11T12:07:16","slug":"bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/","title":{"rendered":"bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US"},"content":{"rendered":"Expected to deliver up to $160 million in cost savings over the next two years and extend the Company\u2019s cash runway through pivotal upcoming milestones in the first half of 2023\n\n\nManagement team to host conference call today, April 5, 2022 at 8:00 am ET\n\nCAMBRIDGE, Mass.--(BUSINESS WIRE)--Following a review of its strategic priorities, bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Company is initiating a comprehensive restructuring intended to deliver up to $160 million in cost savings over the next two years.\n\n\n\nbluebird intends to sharpen its focus on near-term catalysts, including anticipated FDA approvals for its gene therapies for beta-thalassemia and cerebral adrenoleukodystrophy in 2022, and the potential submission o
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

Expected to deliver up to $160 million in cost savings over the next two years and extend the Company\u2019s cash runway through pivotal upcoming milestones in the first half of 2023 Management team to host conference call today, April 5, 2022 at 8:00 am ET CAMBRIDGE, Mass.–(BUSINESS WIRE)–Following a review of its strategic priorities, bluebird […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-776746","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nbluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US - BeBeez\" \/>\n<meta property=\"og:description\" content=\"Expected to deliver up to $160 million in cost savings over the next two years and extend the Company\u2019s cash runway through pivotal upcoming milestones in the first half of 2023 Management team to host conference call today, April 5, 2022 at 8:00 am ET CAMBRIDGE, Mass.--(BUSINESS WIRE)--Following a review of its strategic priorities, bluebird […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-05T18:00:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-11T12:07:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"olomaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"olomaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/\"},\"author\":{\"name\":\"olomaster\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\"},\"headline\":\"bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US\",\"datePublished\":\"2022-04-05T18:00:26+00:00\",\"dateModified\":\"2023-07-11T12:07:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/\"},\"wordCount\":1339,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/\",\"name\":\"bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-04-05T18:00:26+00:00\",\"dateModified\":\"2023-07-11T12:07:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\",\"name\":\"olomaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"caption\":\"olomaster\"},\"url\":\"https:\/\/bebeez.it\/en\/author\/olomaster\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/","og_locale":"en_US","og_type":"article","og_title":"bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US - BeBeez","og_description":"Expected to deliver up to $160 million in cost savings over the next two years and extend the Company\u2019s cash runway through pivotal upcoming milestones in the first half of 2023 Management team to host conference call today, April 5, 2022 at 8:00 am ET CAMBRIDGE, Mass.--(BUSINESS WIRE)--Following a review of its strategic priorities, bluebird […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/","og_site_name":"BeBeez","article_published_time":"2022-04-05T18:00:26+00:00","article_modified_time":"2023-07-11T12:07:16+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"author":"olomaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"olomaster","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/"},"author":{"name":"olomaster","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518"},"headline":"bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US","datePublished":"2022-04-05T18:00:26+00:00","dateModified":"2023-07-11T12:07:16+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/"},"wordCount":1339,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/","name":"bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-04-05T18:00:26+00:00","dateModified":"2023-07-11T12:07:16+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/bluebird-bio-initiates-restructuring-to-reduce-operating-expenses-and-advance-near-term-opportunities-to-bring-potentially-curative-gene-therapies-to-patients-in-the-us\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518","name":"olomaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","caption":"olomaster"},"url":"https:\/\/bebeez.it\/en\/author\/olomaster\/"}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/776746","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=776746"}],"version-history":[{"count":1,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/776746\/revisions"}],"predecessor-version":[{"id":888606,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/776746\/revisions\/888606"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=776746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=776746"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=776746"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=776746"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=776746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}